What's Instore For Big Pharma In 2017?

What’s Instore For Big Pharma In 2017? The US pharmaceutical industry has had a tough 2016, and according to Morgan Stanley, the outlook for the sector is no better next year. Indeed, according to a lengthy report on the state of the pharmaceutical industry from Morgan, there are few catalysts for the sector’s growth next year and thanks to this the industry will be at the mercy of political decisions. Valeant Pharmaceuticals Intl Inc Downgraded After Ackman Cuts Stake Moody’s: Outlook For Global Pharmaceuticals Stable Despite Growing Anger Specialty Pharma Underperforms S&P 500 For First Time Since 2009 Due to…